Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
We assessed the long-term effect of thalamic deep brain stimulation (DBS) on motor symptoms and progression of Parkinson's disease (PD) in PD patients treated for resting and postural/action tremor. Thalamic DBS was performed in 17 patients with treatment-resistant resting and postural/action tremor. Nine patients were available for follow-up examination a mean of 5.5 years after surgery. Three had tremor-dominant PD. DBS produced marked improvement in resting and postural/action tremor in target upper extremity in all 9 patients, which persisted unchanged at the time of the last follow-up visit 5.5 years after surgery. PD severity with DBS 'on' and 'off' 1 year after surgery was compared to PD severity at the last follow-up visit using UPDRS (Unified Parkinson's Disease Rating Scale) III motor scores and individual motor item subscores. Patients were tested while on medication. There was no significant worsening of tremor, rigidity, speech, postural stability, gait, or axial bradykinesia with DBS either on or off at the last follow-up visit compared to the 12-month visit. UPDRS III motor scores were unchanged. However, global assessment of PD progression and increased mean L-dopa dose and L-dopa equivalent daily dose at the time of last follow-up visit indicated that a progression of PD had occurred.
Department of Neurology, Movement Disorders Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dtarsy@bidmc.harvard.edu
Daniel
D
Tarsy
Lisa
L
Scollins
Kristin
K
Corapi
Siobhan
S
O'Herron
Diana
D
Apetauerova
Thorkild
T
Norregaard
D000368:Aged; D046690:Deep Brain Stimulation / Q000009:adverse effects; D018450:Disease Progression; D005500:Follow-Up Studies; D005684:Gait; D006801:Humans; D018476:Hypokinesia / Q000503:physiopathology; D007980:Levodopa / Q000627:therapeutic use; D008875:Middle Aged; D009048:Motor Skills; D009127:Muscle Rigidity / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D012720:Severity of Illness Index; D013788:Thalamus / Q000503:physiopathology*; D014202:Tremor / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D014705:Verbal Behavior
D007980:Levodopa